Advertisement
Screener

KIORA PHARMACEUTICALS, INC. (KPRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

KIORA PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where KIORA PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $9.96M went out.
  • Fiscal year ended 2025-12-31: from investing, $14.43M came in.
  • Fiscal year ended 2025-12-31: from financing, $265.65K came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.90M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2025-12-31-$9.96M$14.43M$0.00*$4.90M
2024-12-31$8.56M-$22.66M$0.00*$15.50M*$1.34M
2023-12-31-$9.56M$0.00$5.97M*-$3.55M
2022-12-31-$10.43M$6.38K$5.38M$3.24M*-$1.89M
2021-12-31-$10.68M-$157.02K$0.00$17.75M$6.67M
2020-12-31-$7.32M-$244.44K$278.19K$5.00M-$2.59M
2019-12-31-$8.15M$0.00$0.00$1.88M$2.05M*-$4.23M
2018-12-31-$10.84M-$270.00K$10.11M$1.20M*$198.21K
2017-12-31-$6.47M-$37.00K$10.59M$4.17M
2016-12-31-$8.41M$174.75K$3.77M$0.00-$4.73M
2015-12-31-$4.46M-$20.00K$14.10M-$32.63K-$1.45M*$8.23M
2014-12-31-$950.62K$0.00$6.50K$0.00$606.77K*-$334.17K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$1.89M*-$6.89M*-$9.32K*$4.93M*
2026-03-31-$3.16M$5.40M-$1.01K$2.26M
2025-12-31-$2.18M*$5.35M*$0.00*
2025-09-30-$1.27M*$5.74M*$0.00*
2025-06-30-$3.80M*$664.17K*$0.00*
2025-03-31-$2.70M$2.67M$0.00-$21.27K
2024-12-31-$2.25M*$482.68K*$0.00*
2024-09-30$920.06K*-$1.92M*$0.00*$0.00*
2024-06-30-$3.73M*-$21.22M*$0.00*
2024-03-31$13.62M$0.00$0.00$15.25M*$28.82M
2023-12-31-$2.58M*$0.00*
2023-09-30-$2.52M*$0.00*$0.00*
2023-06-30-$1.38M*$0.00*$343.35K*$5.60M*
2023-03-31-$3.07M$0.00$98.96K-$2.58M
2022-12-31-$2.13M*$0.00*$0.00*$3.24M*
2022-09-30-$2.97M*$0.00*$5.38M*
2022-06-30-$2.50M*$0.00*$0.00*
2022-03-31-$2.83M$6.38K$0.00-$2.79M
2021-12-31-$2.92M*-$93.16K*$0.00*
2021-09-30-$2.27M*$0.00*$9.76M*
2021-06-30-$2.92M*-$5.75K*$0.00*
2021-03-31-$2.57M-$58.12K$7.99M$5.42M
2020-12-31-$1.71M*$0.00*$498.69K*
2020-09-30-$1.74M*$0.00*$0.00*
2020-06-30-$1.47M*$0.00*
2020-03-31-$2.40M$4.50M$2.10M
2019-12-31-$2.59M*$0.00*$0.00*$1.88M*$2.03M*
2019-09-30-$2.00M*$0.00*$0.00*
2019-06-30-$1.42M*$0.00*
2019-03-31-$2.15M$0.00-$2.15M
2018-12-31-$2.00M*$0.00*$0.00*-$1.90M*
2018-09-30-$2.78M*$0.00*-$2.70M*
2018-06-30-$1.95M*$10.11M*$791.46K*$8.96M*
2018-03-31-$4.11M$0.00-$4.16M
2017-12-31-$1.45M*-$37.00K*$0.00*-$1.44M*
2017-09-30-$2.52M*$0.00*-$2.52M*
2017-06-30-$2.48M*$0.00*$8.79M*$6.33M*
2017-03-31-$18.60K$0.00$1.80M$1.80M
2016-12-31-$2.05M*$25.00K*$0.00*-$2.02M*
2016-09-30-$2.33M*-$11.00K*-$52.00*-$2.34M*
2016-06-30-$2.68M*-$15.00K*$3.77M*$811.64K*
2016-03-31-$1.35M$175.75K$0.00-$1.18M
2015-12-31-$1.55M*$0.00*$0.00*$0.00*-$1.53M*
2015-09-30-$169.46K*$0.00*$14.10M*$0.00*-$5.28M*$8.65M*
2015-06-30-$972.10K*$0.00*$0.00*$0.00*-$1.01M*
2015-03-31-$1.77M-$20.00K$14.95K$3.84M*$2.12M
2014-12-31-$436.13K*$0.00*$0.00*$0.00*-$144.10K*
2014-09-30-$30.20K*$0.00*$6.50K*$0.00*-$90.72K*
2014-06-30-$53.18K*$0.00*$0.00*-$121.56K*
2014-03-31-$431.10K$0.00$0.00$22.21K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
BIOVIE INC. (BIVI)United States$0.012B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33